• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 3
  3. Authors

Online ISSN: 2515-8260

Volume8, Issue3

The Role of Oncology Pharmacists in optimizing patient care in Chronic Immune Thrombocytopenia

    Bedanta Bhattacharjee Bhargab Deka Nasima Ahmed Bonti Sonowal Arzoo Newar Ashique Ahmed Abu Md Ashif Ikbal Amlanjyoti Rajkhowa Alakesh Bharali Gargi Das Ritu Bharti Ripon Sinha

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 3, Pages 279-292
10.31838/ejmcm.08.03.27

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Immune thrombocytopenia or ITP is an autoimmune disorder in which the body creates autoantibodies against its thrombocytes or platelets that are destroyed, resulting in purpura or minor bleeding spots under the surface. It is most often found in cancer patients and is of growing concern.While the main causes of thrombocytopenia in cancer pat ients are chemotherapy and radiation, other aetiologies should also be considered in patients suffering
 from this debilitating disease. Thrombocytopenia causes a variety of complications in the treatment of cancer patients and therefore pharmacists need to be familiar with epidemiology, pathophysiology, risk factors, diagnostic methods, and emerging therapeutic options for chronic immune thrombocytopenia to help oncologists identify and implement realistic treatment measures for chronic immune thrombocytopenia patients undergoing cancer treatment.The objective of this review is to provide a brief overview of chronic immune thrombocytopenia and various strategies for the clinical management of the disease.
Keywords:
    Immune thrombocytopenia Autoimmune Chemotherapy Clinical management
  • PDF (452 K)
  • XML
(2021). The Role of Oncology Pharmacists in optimizing patient care in Chronic Immune Thrombocytopenia. European Journal of Molecular & Clinical Medicine, 8(3), 279-292. doi: 10.31838/ejmcm.08.03.27
Bedanta Bhattacharjee; Bhargab Deka; Nasima Ahmed; Bonti Sonowal; Arzoo Newar; Ashique Ahmed; Abu Md Ashif Ikbal; Amlanjyoti Rajkhowa; Alakesh Bharali; Gargi Das; Ritu Bharti; Ripon Sinha. "The Role of Oncology Pharmacists in optimizing patient care in Chronic Immune Thrombocytopenia". European Journal of Molecular & Clinical Medicine, 8, 3, 2021, 279-292. doi: 10.31838/ejmcm.08.03.27
(2021). 'The Role of Oncology Pharmacists in optimizing patient care in Chronic Immune Thrombocytopenia', European Journal of Molecular & Clinical Medicine, 8(3), pp. 279-292. doi: 10.31838/ejmcm.08.03.27
The Role of Oncology Pharmacists in optimizing patient care in Chronic Immune Thrombocytopenia. European Journal of Molecular & Clinical Medicine, 2021; 8(3): 279-292. doi: 10.31838/ejmcm.08.03.27
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 492
  • PDF Download: 511
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus